drospirenone has been researched along with Hyperkalemia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colli, E; Palacios, S; Regidor, PA | 1 |
Clifford, CR; Cutone, J; Eng, PM; Foegh, M; Loughlin, J; Seeger, JD; Walker, AM | 1 |
Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
Dinger, J; Heinemann, LA | 1 |
Benda, N; Blode, H; Cronin, M; Küfner, A; Schürmann, R | 1 |
Loughlin, J; Mona Eng, P; Oh, K; Seeger, JD; Walker, AM | 1 |
Blode, H; Kunz, M; Schütt, B | 1 |
Dal Pan, GJ; McAdams, M; Staffa, JA | 1 |
2 review(s) available for drospirenone and Hyperkalemia
Article | Year |
---|---|
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Safety of a new oral contraceptive containing drospirenone.
Topics: Adult; Androstenes; Clinical Trials as Topic; Contraceptives, Oral; Female; Humans; Hyperkalemia; Mineralocorticoid Receptor Antagonists; Risk Factors; Venous Thrombosis | 2004 |
3 trial(s) available for drospirenone and Hyperkalemia
Article | Year |
---|---|
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
Topics: Adult; Androstenes; Contraceptives, Oral; Female; Humans; Hyperkalemia; Metrorrhagia; Pregnancy; Pregnancy Rate; Prospective Studies; Pulmonary Embolism; Treatment Failure; Venous Thrombosis; Young Adult | 2019 |
Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function.
Topics: Adult; Androstenes; Creatinine; Female; Humans; Hyperkalemia; Middle Aged; Mineralocorticoid Receptor Antagonists; Models, Biological; Potassium; Reference Values; Regression Analysis; Renal Insufficiency; Severity of Illness Index; Sodium | 2006 |
Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.
Topics: Aged; Androstenes; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Drug Combinations; Drug Interactions; Estradiol; Female; Humans; Hyperkalemia; Indomethacin; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Potassium | 2007 |
4 other study(ies) available for drospirenone and Hyperkalemia
Article | Year |
---|---|
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Topics: Adult; Androstenes; Cohort Studies; Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Logistic Models; Mineralocorticoid Receptor Antagonists; Outcome Assessment, Health Care; Risk; United States; United States Food and Drug Administration | 2008 |
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Child; Contraceptives, Oral, Combined; Drug Monitoring; Drug Utilization; Ethinyl Estradiol; Female; Guideline Adherence; Humans; Hyperkalemia; Insurance Claim Review; Middle Aged; Potassium; Practice Patterns, Physicians'; Progesterone Congeners; United States | 2007 |
The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs.
Topics: Adult; Androstenes; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Contraceptives, Oral, Hormonal; Databases, Factual; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Hyperkalemia; Medical Audit; Mineralocorticoid Receptor Antagonists; Practice Patterns, Physicians'; Retrospective Studies; Sodium Channel Blockers | 2007 |